Tea and health: Preventive and therapeutic usefulness in the elderly?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 12, Issue 1, 2009, Pages 42-48

  Bolling, Bradley W ^a   Chen, Chung Yen Oliver ^a   Blumberg, Jeffrey B ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Cancer; Cardiovascular disease; Catechins; Elderly; Tea; Weight control

Indexed keywords

BLACK TEA EXTRACT; CAFFEINE; CATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GREEN TEA EXTRACT; PLACEBO; THEANINE;

BODY MASS; BODY WEIGHT; BONE DENSITY; BREAST CANCER; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; ELDERLY CARE; ENERGY METABOLISM; HEADACHE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LEUKEMIA; LIVER CANCER; LIVER CELL CARCINOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVARY CANCER; PARKINSON DISEASE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; REVIEW; SKIN CANCER; STOMACH CANCER; TEA; TREATMENT OUTCOME; WEIGHT CONTROL;

AGED; BONE DENSITY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DRUG SYNERGISM; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; OBESITY; TEA;

EID: 58149117537     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32831b9c48     Document Type: Review

References (82)

1. Song WO, Chun OK. Tea is the major source of flavan-3-ol and flavonol in the U.S. diet. J Nutr 2008; 138:1543S-1547S.
2. Zhong L, Furne JK, Levitt MD. An extract of black, green, and mulberry teas causes malabsorption of carbohydrate but not of triacylglycerol in healthy volunteers. Am J Din Nutr 2006; 84:551-555.
3. Hsu TF, Kusumoto A, Abe K, et al. Polyphenol-enriched oolong tea increases fecal lipid excretion. Eur J Clin Nutr 2006; 60:1330-1336.
4. Chan CC, Koo MW, Ng EH, et al. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome - a randomized placebo-controlled trial. J Soc Gynecol Investig 2006; 13:63-68.
5. Rudelle S, Ferruzzi MG, Cristiani I, et al. Effect of a thermogenic beverage on 24-h energy metabolism in humans. Obesity (Silver Spring) 2007; 15:349-355.
6. Auvichayapat P, Prapochanung M, Tunkamnerdthai O, et al. Effectiveness of green tea on weight reduction in obese Thais: a randomized, controlled trial. Physiol Behav 2008; 93:486-491.
7. Boschmann M, Thielecke F. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J Am Coll Nutr 2007; 26:389S-395S.
8. Venables MC, Hulston CJ, Cox HR, Jeukendrup AE. Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr 2008; 87:778-784.
9. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 2007; 15:1473-1483. Evidence from an RCT that green tea decreases body weight and body fat in Japanese individuals.
10. Hill AM, Coates AM, Buckley JD, et al. Can EGCG reduce abdominal fat in obese subjects? J Am Coll Nutr 2007; 26:396S-402S. Evidence from an RCT that EGCG does not provide any benefit for total body fat and weight loss in Australians.
11. Diepvens K, Kovacs EM, Vogels N, Westerterp-Plantenga MS. Metabolic effects of green tea and of phases of weight loss. Physiol Behav 2006; 87:185-191.
12. Fukino Y, Ikeda A, Maruyama K, et al. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 2007; 62:953-960.
13. Van Dorsten FA, Daykin CA, Mulder TP, Van Duynhoven JP. Metabonomics approach to determine metabolic differences between green tea and black tea consumption. J Agric Food Chem 2006; 54:6929-6938.
14. Polychronopoulos E, Zeimbekis A, Kastorini CM, et al. Effects of black and green tea consumption on blood glucose levels in nonobese elderly men and women from Mediterranean Islands (MEDIS epidemiological study). Eur J Nutr 2008; 47:10-16.
15. Mackenzie T, Brooks B, O'Connor G. Beverage intake, diabetes, and glucose control of adults in America. Ann Epidemiol 2006; 16:688-691.
16. Ryu OH, Lee J, Lee KW, et al. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 2006; 71:356-358.
17. Mackenzie T, Leary L, Brooks WB. The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. Metabolism 2007; 56:1340-1344.
18. Bryans JA, Judd PA, Ellis PR. The effect of consuming instant black tea on postprandial plasma glucose and insulin concentrations in healthy humans. J Am Coll Nutr 2007; 26:471-477. Demonstration of an acute benefit of black tea on plasma glucose and insulin during an oral glucose tolerance test.
19. Basu A, Lucas EA. Mechanisms and effects of green tea on cardiovascular health. Nutr Rev 2007; 65:361-375.
20. Grassi D, Aggio A, Onori L, et al. Tea, flavonoids, and nitric oxide-mediated vascular reactivity. J Nutr 2008; 138:1554S-1560S.
21. Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr 2008; 138:1548S-1553S.
22. Shenouda SM, Vita JA. Effects of flavonoid-containing beverages and EGCG on endothelial function. J Am Coll Nutr 2007; 26:366S-372S.
23. Stangl V, Dreger H, Stangl K, Lorenz M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 2007; 73:348-358.
24. Tipoe GL, Leung TM, Hung MW, Fung ML. Green tea polyphenols as an antioxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets 2007; 7:135-144.
25. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 2007; 26:373S-388S.
26. Debette S, Courbon D, Leone N, et al. Tea consumption is inversely associated with carotid plaques in women. Arterioscler Thromb Vasc Biol 2008; 28:353-359.
27. Steptoe A, Gibson EL, Vuononvirta R, et al. The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial. Atherosclerosis 2007; 193:277-282.
28. Hsu SP, Wu MS, Yang CC, et al. Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. Am J Clin Nutr 2007; 86:1539-1547.
29. Inami S, Takano M, Yamamoto M, et al. Tea catechin consumption reduces circulating oxidized low-density lipoprotein. Int Heart J 2007; 48:725-732.
30. Mukamal KJ, MacDermott K, Vinson JA, et al. A 6-month randomized pilot study of black tea and cardiovascular risk factors. Am Heart J 2007; 154:724e1-724e6.
31. Jochmann N, Lorenz M, Krosigk A, et al. The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br J Nutr 2008; 99:863-868.
32. Alexopoulos N, Vlachopoulos C, Aznaouridis K, et al. The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil 2008; 15:300-305.
33. Ardalan MR, Tarzamni MK, Shoja MM, et al. Black tea improves endothelial function in renal transplant recipients. Transplant Proc 2007; 39:1139-1142.
34. Lorenz M, Jochmann N, von Krosigk A, et al. Addition of milk prevents vascular protective effects of tea. Eur Heart J 2007; 28:219-223.
35. Devine A, Hodgson JM, Dick IM, Prince RL. Tea drinking is associated with benefits on bone density in older women. Am J Clin Nutr 2007; 86:1243-1247. Observational data from elderly women in Australia revealing a positive association of tea intake with BMD and suggesting a reduced risk of osteoporosis with tea consumption.
36. ••]).
37. Hallanger Johnson JE, Kearns AE, Doran PM, et al. Fluoride-related bone disease associated with habitual tea consumption. Mayo Clin Proc 2007; 82:719-724.
38. Mandel SA, Amit T, Kalfon L, et al. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr 2008; 138:1578S-1583S.
39. Ng TP, Feng L, Niti M, et al. Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr 2008; 88:224-231. Observational evidence from an elderly cohort of a dose-related reduction in the risk of cognitive impairment and decline with tea intake.
40. Hu G, Bidel S, Jousilahti P, et al. Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord 2007; 22:2242-2248.
41. Tan LC, Koh WP, Yuan JM, et al. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. Am J Epidemiol 2008; 167:553-560.
42. Kandinov B, Giladi N, Korczyn AD. Smoking and tea consumption delay onset of Parkinson's disease. Parkinsonism Relat Disord 2008 [Epub ahead of print]. doi:10.1016/j.parkreldis.2008.02.01 1.
43. Kandinov B, Giladi N, Korczyn AD. The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease. Parkinsonism Relat Disord 2007; 13:243-245.
44. Lovallo WR, Farag NH, Vincent AS, et al. Cortisol responses to mental stress, exercise, and meals following caffeine intake in men and women. Pharmacol Biochem Behav 2006; 83:441-447.
45. Steptoe A, Gibson EL, Vuononvirta R, et al. The effects of tea on psychophysiological stress responsivity and poststress recovery: a randomised double-blind trial. Psychopharmacology (Berl) 2007; 190:81-89. RCT evidence that a black tea extract lowers posttask Cortisol concentrations and increases the subjective evaluation of relaxation during the recovery period.
46. Haskell CF, Kennedy DO, Milne AL, et al. The effects of L-theanine, caffeine and their combination on cognition and mood. Biol Psychol 2008; 77:113-122.
47. Nobre AC, Rao A, Owen GN. L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr 2008; 17S1:167-168.
48. Rogers PJ, Smith JE, Heatherley SV, Pleydell-Pearce CW. Time for tea: mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacology (Berl) 2008; 195:569-577.
49. Kelly SP, Gomez-Ramirez M, Montesi JL, Foxe JJ. L-Theanine and caffeine in combination affect human cognition as evidenced by oscillatory alpha-band activity and attention task performance. J Nutr 2008; 138:1572S-1577S.
50. Khan N, Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 2008; 269:269-280.
51. Landis-Piwowar KR, Huo C, Chen D, et al. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res 2007; 67:4303-4310.
52. Yang CS, Lambert JD, Ju J, et al. Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol Appl Pharmacol 2007; 224:265-273.
53. Na HK, Surh YJ. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem Toxicol 2008; 46:1271-1278.
54. Chow HH, Hakim IA, Vining DR, et al. Modulation of human glutathione s-transferases by polyphenon E intervention. Cancer Epidemiol Biomarkers Prev 2007; 16:1662-1666. A RCT demonstrating a nutrigenomic effect of a GTE on expression of a phase 2 detoxification enzyme important in chemopreventive mechanisms.
55. Tang L, Tang M, Xu L, et al. Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis 2008; 29:411-417. Evidence for the potential efficacy of a GTE in individuals at risk for aflatoxin-induced hepatocellular carcinoma through a reduction in active carcinogens.
56. Alemdaroglu NC, Dietz U, Wolffram S, et al. Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability. Biopharm Drug Dispos 2008; 29:335-348. The first clinical evidence that tea can decrease the bioavailability of folic acid, a putative untoward effect of the beverage.
57. Lemos C, Peters GJ, Jansen G, et al. Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds. Eur J Nutr 2007; 46:329-336.
58. Navarro-Perán E, Cabezas-Herrera J, Campo LS, Rodríguez- López JN. Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate. Int J Biochem Cell Biol 2007; 39:2215-2225.
59. Arts IC. A review of the epidemiological evidence on tea, flavonoids, and lung cancer. J Nutr 2008; 138:1561S-1566S.
60. Liang W, Binns CW, Jian L, Lee AH. Does the consumption of green tea reduce the risk of lung cancer among smokers? Evid Based Complement Alternat Med 2007; 4:17-22.
61. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007; 10:75-83.
62. Yang CS, Ju J, Lu G, et al. Cancer prevention by tea and tea polyphenols. Asia Pac J Clin Nutr 2008; 17S1:245-248.
63. Zhang M, Holman CD, Huang JP, Xie X. Green tea and the prevention of breast cancer: a case-control study in Southeast China. Carcinogenesis 2007; 28:1074-1078.
64. Ganmaa D, Willett WC, Li TY, et al. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 2008; 122:2071-2076.
65. Zhou B, Yang L, Wang L, et al. The association of tea consumption with ovarian cancer risk: a metaanalysis. Am J Obstet Gynecol 2007; 197:594e1-594e6.
66. Song YJ, Kristal AR, Wicklund KG, et al. Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008; 17:712-716.
67. Baker JA, Boakye K, McCann SE, et al. Consumption of black tea or coffee and risk of ovarian cancer. Int J Gynecol Cancer 2007; 17:50-54.
68. Steevens J, Schouten U, Verhage BA, et al. Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer 2007; 97:1291-1294.
69. Adhami VM, Mukhtar H. Antioxidants from green tea and pomegranate for chemoprevention of prostate cancer. Mol Biotechnol 2007; 37:52-57.
70. Kurahashi N, Sasazuki S, Iwasaki M, et al. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 2008; 167:71-77.
71. Jian L, Lee AH, Binns CW. Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr 2007; 16S1:453-457. A case-control study suggesting a synergy between catechins and lycopene, different phytochemicals associated with a chemopreventive action against prostate cancer.
72. Luo J, Inoue M, Iwasaki M, et al. Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 2007; 16:542-548.
73. Lin Y, Kikuchi S, Tamakoshi A, et al. Green tea consumption and the risk of pancreatic cancer in Japanese adults. Pancreas 2008; 37:25-30.
74. Sasazuki S, lnoue M, Miura T, et al. Plasma tea polyphenols and gastric cancer risk: a case-control study nested in a large population-based prospective study in Japan. Cancer Epidemiol Biomarkers Prev 2008; 17:343-351. Evidence from a case-control study indicating a specific, inverse association of plasma ECG with risk of gastric cancer.
75. Zhou Y, Li N, Zhuang W, et al. Green tea and gastric cancer risk: meta-analysis of epidemiologic studies. Asia Pac J Clin Nutr 2008; 17:159-165.
76. Kumar N, Shibata D, Helm J, et al. Green tea polyphenols in the prevention of colon cancer. Front Biosci 2007; 12:2309-2315.
77. Yang G, Shu XO, Li H, et al. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 2007; 16:1219-1223.
78. Katiyar S, Elmets CA, Katiyar SK. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J Nutr Biochem 2007; 18:287-296.
79. Rees JR, Stukel TA, Perry AE, et al. Tea consumption and basal cell and squamous cell skin cancer: results of a case-control study. J Am Acad Dermatol 2007; 56:781-785.
80. Zhang M, Zhao X, Zhang X, Holman CD. Possible protective effect of green tea intake on risk of adult leukaemia. Br J Cancer 2008; 98:168-170.
81. Popkin BM, Armstrong LE, Bray GM, et al. A new proposed guidance system for beverage consumption in the United States. Am J Clin Nutr 2006; 83:529-542.
82. Vogel JH, Bolling SF, Costello RB, et al. Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J Am Coll Cardiol 2005; 46:184-221.